Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
MONTCO.Today on MSN1d
Audubon’s Globus Medical Makes Game-Changing AcquisitionAudubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...
Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
GlobalData on MSN4d
Globus Medical strengthens SCS market position with $250m Nevro dealGlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback